A TEAM PASSIONATE ABOUT BREAKING BOUNDARIES AND DELIVERING NEW POSSIBILITIES
Sapience Therapeutics is a clinical-stage biotechnology company bringing unmatched expertise and bold innovation to one of the toughest challenges in medicine—eliminating hard-to-treat cancers. Whether addressing intracellular drivers of oncogenesis or delivering precision payloads to cancer cells, our SPEARs™ and SPARCs™ are transforming outcomes by targeting what others have deemed unachievable.
BREAKING BOUNDARIES, BUILDING SOLUTIONS
We have advanced what is possible in peptide therapeutics by bringing together experts across peptide chemistry, molecular biology, immunology and oncologic drug development that enable us to identify, engineer and develop stable, high-impact peptides.
ENGINEERING SUCCESS WITH EXPERTLY DESIGNED PLATFORMS
We are changing the tide in the fight against cancer with our cutting-edge peptide discovery and development platforms. Both the ADAPT™ and PADS™ platforms are purpose-built to maximize the translational potential of drug candidates. By combining advanced tools with expert insight, we’re not just developing drugs—we’re defining the future of cancer care.